FDA Advisory Committee Sets Review Date for Mesoblast’s remestemcel-L in Pediatric Steroid-Refractory Acute Graft Versus Host Disease
/
Date22 Jul 2020
Email Print Friendly Share NEW YORK, July 21, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that the Oncologic Drugs Advisory Committee (ODAC)... Read More →
Blue Eye Soft Announces Commodity Designation and FDA Acknowledgement of BLUEDOCAITM — an AI-driven Medical Imaging Clinical Decision Tool
/
Date21 Jul 2020
Email Print Friendly Share About Blue Eye Soft: Blue Eye Soft, the groundbreaking multinational corporation of South Carolina Research Authority SC Launch, U.S. Air Force... Read More →
Philips delivers Q2 sales of EUR 4.4 billion, with 6% comparable sales decrease; income from continuing operations of EUR 213 million, Adjusted EBITA margin of 9.5% and operating cash flow of EUR 558 million
/
Date20 Jul 2020
Email Print Friendly Share July 20, 2020 Second-quarter highlights• Sales amounted to EUR 4.4 billion, with a 6% comparable sales decrease• Comparable order intake increased... Read More →
KRONOS ADVANCED TECHNOLOGIES INC LAUNCHES INDEPENDENT SALES REP PROGRAM ACROSS USA
/
Date19 Jul 2020
Email Print Friendly Share Los Angeles, CA, July 17, 2020 (GLOBE NEWSWIRE) — KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) (“KNOS” or the “Company”), a... Read More →
Genesis Health Clubs Announces Acquisition of all Seven Locations of The Athletic Clubs
/
Date18 Jul 2020
Email Print Friendly Share The expansion strengthens Genesis’ position as the largest fitness provider in the Midwestern United States. The move strengthens and consolidates the... Read More →
엠마우스생명과학 게실증에 대한 엔다리 아웃 라이센싱 주도를 위하여 파트너 인터내셔널과 계약 체결
/
Date17 Jul 2020
Email Print Friendly Share 캘리포니아주 토랜스, July 17, 2020 (GLOBE NEWSWIRE) — 겸상적혈구질환 치료의 선두주자인 Emmaus Life Sciences, 엠마우스생명과학, (“엠마우스”, OTCQB: EMMA)은 게실증 치료에 사용되는... Read More →
NeuroRx and Relief Therapeutics Announce Data Monitoring Committee Determination to Continue Phase 2/3 Trial of RLF-100 for Critical COVID-19
/
Date16 Jul 2020
Email Print Friendly Share With resurgent COVID-19, enrollment has accelerated in Miami, Houston, and Irvine Data Monitoring Committee determined that so far RLF-100 has generated... Read More →
ObsEva SA Awarded Clinical Science Award for Oral Presentation at ESHRE Virtual 36th Annual Meeting, July 2020
/
Date15 Jul 2020
Email Print Friendly Share Geneva, Switzerland and Boston, MA – July 15, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and... Read More →
Galera Therapeutics Completes Enrollment of Phase 1b/2a Clinical Trial of GC4419 in Combination with Radiotherapy for Locally Advanced Pancreatic Cancer
/
Date14 Jul 2020
Email Print Friendly Share MALVERN, Pa., July 13, 2020 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and... Read More →
Junshi Biosciences Announces Completion of Enrollment in Phase I Trial of SARS-CoV-2 Neutralizing Antibody JS016 in China
/
Date13 Jul 2020
Email Print Friendly Share SHANGHAI, China, July 12, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery,... Read More →